Cargando…
Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV
Little is known about the impact of social distancing on health-related quality of life and depressive symptoms in older people with HIV during the COVID-19 pandemic. SETTING: HIV-positive and HIV-negative AGE(h)IV Cohort Study participants. METHOD: In September-November 2020, participants completed...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561239/ https://www.ncbi.nlm.nih.gov/pubmed/36252241 http://dx.doi.org/10.1097/QAI.0000000000003055 |
_version_ | 1784807907418701824 |
---|---|
author | Schaaf, Reja E. A. Verburgh, Myrthe L. Boyd, Anders Wit, Ferdinand W. Nieuwkerk, Pythia T. Schim van der Loeff, Maarten F. Reiss, Peter |
author_facet | Schaaf, Reja E. A. Verburgh, Myrthe L. Boyd, Anders Wit, Ferdinand W. Nieuwkerk, Pythia T. Schim van der Loeff, Maarten F. Reiss, Peter |
author_sort | Schaaf, Reja E. A. |
collection | PubMed |
description | Little is known about the impact of social distancing on health-related quality of life and depressive symptoms in older people with HIV during the COVID-19 pandemic. SETTING: HIV-positive and HIV-negative AGE(h)IV Cohort Study participants. METHOD: In September-November 2020, participants completed questionnaires on social distancing, change in substance use, health-related quality of life (EQ-6D, including EQ-VAS), and depressive symptoms (PHQ-9). Associations between social distancing and (1) EQ-VAS or (2) PHQ-9 score ≥10 (clinically relevant depressive symptoms) were analyzed using fractional and binomial logistic regression, respectively. RESULTS: Two hundred fourteen HIV-positive and 285 HIV-negative participants were analyzed. 77.4% found social distancing important and 66.9% reported good adherence to these measures, without significant differences between HIV-positive and HIV-negative participants. In both groups, <5% reported increased smoking or recreational drug use, but more HIV-positive (12.2%) than HIV-negative (4.9%) participants (P = 0.005) reported increased/more frequent alcohol use. Median EQ-VAS was slightly lower in HIV-positive (80 IQR = 73–90) than HIV-negative (84 IQR = 75–90) participants (P = 0.041). The prevalence of clinically relevant depressive symptoms was similar (HIV-positive, 8.4% and HIV-negative, 8.8%). Worrying about contracting COVID-19 and having ≥3 (vs no) comorbidities were associated with lower EQ-VAS and finding social distancing easy with higher EQ-VAS. Worrying about contracting COVID-19 and younger than 60 years (vs ≥65) were associated with higher odds of clinically relevant depressive symptoms. HIV status was associated with neither outcome. CONCLUSIONS: Initially during the COVID-19 pandemic in the Netherlands, a similar majority of HIV-positive and HIV-negative participants reported adhering to social distancing. Irrespective of HIV status, concerns about contracting COVID-19 negatively affected participants' perceived current health and increased risk of depressive symptoms. |
format | Online Article Text |
id | pubmed-9561239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | JAIDS Journal of Acquired Immune Deficiency Syndromes |
record_format | MEDLINE/PubMed |
spelling | pubmed-95612392022-10-19 Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV Schaaf, Reja E. A. Verburgh, Myrthe L. Boyd, Anders Wit, Ferdinand W. Nieuwkerk, Pythia T. Schim van der Loeff, Maarten F. Reiss, Peter J Acquir Immune Defic Syndr Epidemiology Little is known about the impact of social distancing on health-related quality of life and depressive symptoms in older people with HIV during the COVID-19 pandemic. SETTING: HIV-positive and HIV-negative AGE(h)IV Cohort Study participants. METHOD: In September-November 2020, participants completed questionnaires on social distancing, change in substance use, health-related quality of life (EQ-6D, including EQ-VAS), and depressive symptoms (PHQ-9). Associations between social distancing and (1) EQ-VAS or (2) PHQ-9 score ≥10 (clinically relevant depressive symptoms) were analyzed using fractional and binomial logistic regression, respectively. RESULTS: Two hundred fourteen HIV-positive and 285 HIV-negative participants were analyzed. 77.4% found social distancing important and 66.9% reported good adherence to these measures, without significant differences between HIV-positive and HIV-negative participants. In both groups, <5% reported increased smoking or recreational drug use, but more HIV-positive (12.2%) than HIV-negative (4.9%) participants (P = 0.005) reported increased/more frequent alcohol use. Median EQ-VAS was slightly lower in HIV-positive (80 IQR = 73–90) than HIV-negative (84 IQR = 75–90) participants (P = 0.041). The prevalence of clinically relevant depressive symptoms was similar (HIV-positive, 8.4% and HIV-negative, 8.8%). Worrying about contracting COVID-19 and having ≥3 (vs no) comorbidities were associated with lower EQ-VAS and finding social distancing easy with higher EQ-VAS. Worrying about contracting COVID-19 and younger than 60 years (vs ≥65) were associated with higher odds of clinically relevant depressive symptoms. HIV status was associated with neither outcome. CONCLUSIONS: Initially during the COVID-19 pandemic in the Netherlands, a similar majority of HIV-positive and HIV-negative participants reported adhering to social distancing. Irrespective of HIV status, concerns about contracting COVID-19 negatively affected participants' perceived current health and increased risk of depressive symptoms. JAIDS Journal of Acquired Immune Deficiency Syndromes 2022-11-01 2022-07-13 /pmc/articles/PMC9561239/ /pubmed/36252241 http://dx.doi.org/10.1097/QAI.0000000000003055 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Epidemiology Schaaf, Reja E. A. Verburgh, Myrthe L. Boyd, Anders Wit, Ferdinand W. Nieuwkerk, Pythia T. Schim van der Loeff, Maarten F. Reiss, Peter Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV |
title | Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV |
title_full | Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV |
title_fullStr | Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV |
title_full_unstemmed | Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV |
title_short | Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV |
title_sort | change in substance use and the effects of social distancing on health-related quality of life and depressive symptoms during the covid-19 pandemic in people living with and without hiv |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561239/ https://www.ncbi.nlm.nih.gov/pubmed/36252241 http://dx.doi.org/10.1097/QAI.0000000000003055 |
work_keys_str_mv | AT schaafrejaea changeinsubstanceuseandtheeffectsofsocialdistancingonhealthrelatedqualityoflifeanddepressivesymptomsduringthecovid19pandemicinpeoplelivingwithandwithouthiv AT verburghmyrthel changeinsubstanceuseandtheeffectsofsocialdistancingonhealthrelatedqualityoflifeanddepressivesymptomsduringthecovid19pandemicinpeoplelivingwithandwithouthiv AT boydanders changeinsubstanceuseandtheeffectsofsocialdistancingonhealthrelatedqualityoflifeanddepressivesymptomsduringthecovid19pandemicinpeoplelivingwithandwithouthiv AT witferdinandw changeinsubstanceuseandtheeffectsofsocialdistancingonhealthrelatedqualityoflifeanddepressivesymptomsduringthecovid19pandemicinpeoplelivingwithandwithouthiv AT nieuwkerkpythiat changeinsubstanceuseandtheeffectsofsocialdistancingonhealthrelatedqualityoflifeanddepressivesymptomsduringthecovid19pandemicinpeoplelivingwithandwithouthiv AT schimvanderloeffmaartenf changeinsubstanceuseandtheeffectsofsocialdistancingonhealthrelatedqualityoflifeanddepressivesymptomsduringthecovid19pandemicinpeoplelivingwithandwithouthiv AT reisspeter changeinsubstanceuseandtheeffectsofsocialdistancingonhealthrelatedqualityoflifeanddepressivesymptomsduringthecovid19pandemicinpeoplelivingwithandwithouthiv |